Your contact person
Manager PR & Communications Jan Phillip Denkers
Scientists film shock waves in diamond
Researchers have used ultra-short pulses of X-rays to film shock waves in diamonds. The study headed by DESY scientists opens up new possibilities for ...
Read more …
EndoChoice announces Launch of its Initial Public Offering
EndoChoice today announced the launch of its initial public offering of 6,250,000 shares of its common stock, which will represent 25.6% of its outstanding ...
Read more …
Innovation award for DESY start-up
With an innovative high-speed X-ray camera, the DESY spin-off X-Spectrum GmbH has won the Hamburg Innovation Award in the category Start. The newly developed ...
Read more …
EU funds nanotech research project
DESY is involved in a new EU project that aims to coordinate nanoscientific research in Europe. NFFA Europe (NFFA stands for “Nanoscience Foundries and ...
Read more …
Kiel researchers build the world’s smallest machines
Great excitement at Kiel University: As the DFG (German Research Foundation) announced today (Thursday, May 21), it will continue to support the research on ...
Read more …
Breakthrough in basic research: Kiel researchers discover new means against cancerous tumours
Researchers at the Institute of Pharmacy at Kiel University have developed chemical compounds which have demonstrated strong effects on tumours. The so-called "aromatic heterocyclic ...
Read more …
Facio partners with Evotec and initiates FSHD drug discovery programme
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and Facio Therapies ("Facio") announced today that they have entered into an agreement aimed at ...
Read more …
Scientists X-ray anti-inflammatory drug candidates
Using DESY's ultra bright X-ray source PETRA III, scientists have decoded the molecular and three-dimensional structure of two promising drug candidates from the new ...
Read more …
William R. Gruver agrees to lead INDIVUMED business advisory team
Past General Partner and Chief Administrative Officer of the Equities Division of Goldman, Sachs & Co. and current member of the Board of Directors ...
Read more …
Vaccine reliably activates the immune system response against Ebola
The initial results of a clinical Phase I trial of a potential vaccine against the dreaded Ebola virus are now available at the Hamburg-Eppendorf ...
Read more …
“FBÖ TransTechTrans” pilot phase ended – still vouchers to apply for
The pilot phase of the Swedish-Danish-German "FBÖ TransTechTrans” project has ended but Danish companies and research institutions within life sciences still have an opportunity ...
Read more …
Attack from all sides
Tuberculosis – a disease that knows no boundaries, kills millions of people per year worldwide and is developing resistance to current drug therapies at ...
Read more …